CSIMarket
 
12 Retech Corporation  (RETC)
Other Ticker:  
 
    Sector  Technology    Industry Software & Programming
   Industry Software & Programming
   Sector  Technology
 
Price: $0.0005 $0.00 0.000%
Day's High: $0.0005 Week Perf: -16.67 %
Day's Low: $ 0.00 30 Day Perf: -16.67 %
Volume (M): 226,695 52 Wk High: $ 0.02
Volume (M$): $ 113 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) 2
 Shares Outstanding (Millions) 4,453
 Employees 4
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -2
 Cash Flow (TTM) (Millions $) -0
 Capital Exp. (TTM) (Millions $) -0

12 Retech Corporation
At our core, we are a software company whose technology allows retailers to combat the dual threats of Walmart and Amazon — both online and in physical stores. Our microbrand rollup acquisition strategy allows us to demonstrate the effectiveness of our software, devise and test new products, while providing shareholder value through immediate revenue and earnings growth. The Company operates through our subsidiaries on three continents


   Company Address: 515 E Phoenix 85004 AZ
   Company Phone Number: 539-4329   Stock Exchange / Ticker: RETC
   RETC is expected to report next financial results on November 12, 2021.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
IBM        1.62% 
• View Complete Report
   



Mamamancini s Holdings Inc

Mamamancini S Holdings Inc announced financial period ending Jul 31 2021 operating profit of $0.584913 millions

Company's earnings deteriorated despite Sales growth in the financial period ending Jul 31 2021, earnings per share plummeted by -50% to $0.01 per share, while Sales increased in double digits by 16.18% to $12.06 millions, from the same quarter a year ago.

Income faded from the preceding quarter by -50% from $0.02 per share, Sales improved by 16.98 % from $10.31 millions.

Luckwel Pharmaceuticals Inc

Luckwel Pharmaceuticals Inc announced fourth quarter of 2021 earnings season operating shortfall of $-0.21477 millions

In the fourth quarter of 2021 earnings season Luckwel Pharmaceuticals Inc reached break-even of $-0.00 per share compared to $-0.00 a year ago and from $-0.00 per share from the previous quarter.

Luckwel Pharmaceuticals Inc reported operating loss of $-0.21477 millions, in the fourth quarter of 2021 earnings season, a deterioration from the operating shortfall of $-0.150485 millions, realized in fourth quarter of 2020
Luckwel Pharmaceuticals Inc reported net loss of $-0.44 millions and Sales of $0.00 millions for the fiscal year 2021.

Company reported break-even compared to $-0.00 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.

Domo Inc

Despite Surge in Sales Profitability not Reached

Domo Inc announced in the second quarter of 2021 surge in Sales by 22.87% to $62.83 millions from the same quarter a year ago, but it has increased losses at $-0.70 per share.

Sequentially increased losses from $-0.58 per share and Sales increased by 4.6 % from $60.06 millions.

Pro Dex Inc

Sharp drop in EPS, Sales Weak

In the fiscal period ending Jun 30 2021 Pro Dex Inc eps dived by -66.22% of $0.11 per share compared to $0.32 a year ago and eps dropped by -78.33% from $0.50 per share from the previous quarter.

Sales declined in double digits by -15.19% to $9.44 millions from $11.13 millions in the same quarter a year ago and sequentially Sales fell by -19.63% from $11.74 millions.
In the fiscal year 2021, Pro Dex Inc reported Sales of $38.03 millions and net income of $4.45 millions.

Earnings deteriorated by -24.67 % to $1.13 per share from $1.50 in the previous fiscal year, while Sales advanced by 9.17 % from $34.83 millions a year ago.

Aerovironment Inc

Aerovironment Inc announced fiscal period ending Jul 31 2021 operating loss of $-12.113 millions

In the fiscal period ending Jul 31 2021 Aerovironment Inc increased losses of $-0.57 per share compared to $-0.04 a year ago and eps fell from $0.27 per share from the previous quarter.

Sales grew strongly by 63.2% to $101.01 millions from $61.89 millions in the same quarter a year ago and sequentially Sales Tumbled by -37.76% from $162.30 millions.






 

12 Retech's Segments
 
 
• View Complete Report


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ROVR's Profile

Stock Price

ROVR's Financials

Business Description

Fundamentals

Charts & Quotes

ROVR's News

Suppliers

ROVR's Competitors

Customers & Markets

Economic Indicators

ROVR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071